Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD
Psychopharmacology Bulletin · 2026
DOI: 10.64719/pb.18510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology Bulletin, 2026. Verfasst von Luke Rozema und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rozema, MS, Veterans Affairs Medical Center, White River Junction, Vermont. Hauptthemen laut MEDLINE: Sulfonamides, Benzimidazoles, Pyrrolidines, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Inflammation has been proposed as a possible mechanism and treatment target for posttraumatic stress disorder (PTSD), but traditional methods for measuring it are performed infrequently in clinical practice. The present study sought to determine if widely available complete blood count (CBC)-derived indices of inflammation predicted treatment response to Glecaprevir/Pibrentasvir (GLE/PIB), a potential inflammation modulator, in patients with PTSD.
Methods
We performed a secondary analysis of an uncontrolled trial of GLE/PIB in 10 patients with PTSD. Nearest CBC lab tests were taken from the Veterans Affairs electronic health record, and six CBC-derived indices of inflammation were calculated and Z-standardized. The effect of the indices on PTSD symptoms following GLE/PIB treatment, as measured by the Clinician Administered PTSD Scale for DSM-5 (CAPS), was determined through multiple linear regression.
Results
Four of the six indices of inflammation tested had statistically significant associations with post-treatment CAPS scores at an α = 0.05 significance level. Regression coefficients for the statistically significant findings ranged from −19.56 (95% CI: −28.99, −10.14) to −14.24 (95% CI: −25.51, −2.98), indicating lower post-treatment CAPS scores in patients with greater inflammatory indices.
Conclusions
CBC-derived indices of inflammation may be an efficient and widely available biomarker for predicting treatment response in medications targeting potential inflammatory mechanisms of PTSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rozema, MS, Veterans Affairs Medical Center, White River Junction, Vermont.
- Watts, MD, MPH, Veterans Affairs Medical Center, White River Junction, Vermont; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT.
- Shiner, MD, MPH, Veterans Affairs Medical Center, White River Junction, Vermont; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH; Department of Psychi…
Zitieren
APA
Rozema, L., Watts, B. V., & Shiner, B. (2026). Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.18510
Vancouver
Rozema L, Watts BV, Shiner B. Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD. Psychopharmacology Bulletin. 2026. doi:10.64719/pb.18510
BibTeX
@article{Rozema2026,
author = {Rozema, Luke and Watts, Bradley V and Shiner, Brian},
title = {Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD},
journal = {Psychopharmacology Bulletin},
year = {2026},
doi = {10.64719/pb.18510}
}
EUVIMED